{"id":"18f-psma-pet","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site reaction"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through a positron emission tomography (PET) imaging technique, allowing for the detection of PSMA-expressing cells in the body. PSMA is a protein that is highly expressed in prostate cancer cells, making it an ideal target for imaging and treatment.","oneSentence":"binds to prostate-specific membrane antigen (PSMA) to visualize prostate cancer","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:56:26.031Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer imaging"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"[18F]PSMA-PET","genericName":"[18F]PSMA-PET","companyName":"Region Västerbotten","companyId":"region-v-sterbotten","modality":"Small molecule","firstApprovalDate":"","aiSummary":"binds to prostate-specific membrane antigen (PSMA) to visualize prostate cancer Used for Prostate cancer imaging.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":false,"score":3}}